A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy

A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy

In the News

15 May 2014Karus Therapeutics features in SciBX

Oxford, UK, 15 May 2014 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, was featured in the cover story of SciBX, ‘Chromatin’s rising tide’. The article, which covers the discussions of a panel of thought leaders at the SciBX Summit on Innovation in Drug Discovery, outlines a road map for how to capitalize on the full range of possible chromatin targets in and beyond oncology. The piece determines how industry and academia must develop tools that can flesh out how and when chromatin dysfunction drives diseases.